Bilaketaren emaitzak - Han‐Zhang, Han

The prevalence and prognostic value of KRAS co‐mutation subtypes in Chinese advanced non‐small cell lung cancer patients nork Cai, Dongjing, Hu, Chengping, Li, Li, Deng, Shichao, Yang, Jing, Han‐Zhang, Han, Li, Min

Testu osoa Testu osoa Testu osoa

An EGFR-Amplified Cervical Squamous Cell Carcinoma Patient with Pulmonary Metastasis Benefits from Afatinib: A Case Report nork Chen, Qian, Huang, Yihua, Shao, Lin, Han-Zhang, Han, Yang, Fan, Wang, Yang, Liu, Jing, Gan, Jiadi

Testu osoa Testu osoa Testu osoa

Efficacy of afatinib in a HER2 amplification-positive endometrioid adenocarcinoma patient– a case report nork Zhou, Li, Ren, Yifeng, Wang, Xia, Miao, Dongliu, Lizaso, Analyn, Li, Haiyan, Han-Zhang, Han, Qian, Jun, Yang, Hui

Testu osoa Testu osoa Testu osoa

Exceptional Response of Cryoablation Followed by Pembrolizumab in a Patient with Metastatic Cervical Carcinosarcoma with High Tumor Mutational Burden: A Case Report nork Zhu, Baorang, Liu, Ying, Li, Jing, Diao, Liyan, Shao, Lin, Han‐Zhang, Han, Zhang, Lu, Kang, Qiaolin, Yang, Wuwei

Testu osoa Testu osoa Testu osoa

Perioperative Circulating Tumor DNA in Colorectal Liver Metastases: Concordance with Metastatic Tissue and Predictive Value for Tumor Burden and Prognosis nork He, Yiping, Ma, Xiaoji, Chen, Ke, Liu, Fangqi, Cai, Sanjun, Han-Zhang, Han, Hou, Ting, Xiang, Jianxing, Peng, Junjie

Testu osoa Testu osoa Testu osoa

Clinicopathologic features and genomic analysis of pulmonary blastomatoid carcinosarcoma nork Zhao, Jikai, Xiang, Chan, Zhao, Ruiying, Guo, Ping, Zheng, Jingjing, Han-Zhang, Han, Yu, Keke, Zhang, Jie, Han, Yuchen

Testu osoa Testu osoa Testu osoa

Maximum allele frequency observed in plasma: A potential indicator of liquid biopsy sensitivity nork Tang, Yong, Liu, Xianling, Ou, Zhu'An, He, Zhe, Zhu, Qihang, Wang, Ye, Yang, Mei, Ye, Junyi, Han-Zhang, Han, Qiao, Guibin

Testu osoa Testu osoa Testu osoa

The association between BRAF mutation class and clinical features in BRAF-mutant Chinese non-small cell lung cancer patients nork Lin, Quan, Zhang, Haoran, Ding, Huaxin, Qian, Jun, Lizaso, Analyn, Lin, Jing, Han-Zhang, Han, Xiang, Jianxing, Li, Yuping, Zhu, Hong

Testu osoa Testu osoa Testu osoa

Somatic POLE exonuclease domain mutations elicit enhanced intratumoral immune responses in stage II colorectal cancer nork Mo, Shaobo, Ma, Xiaoji, Li, Yaqi, Zhang, Long, Hou, Ting, Han-Zhang, Han, Qian, Juanjuan, Cai, Sanjun, Huang, Dan, Peng, Junjie

Testu osoa Testu osoa Testu osoa

Targeted Sequencing Analysis of Predominant Histological Subtypes in Resected Stage I Invasive Lung Adenocarcinoma nork Li, Yan, Tan, Yan, Hu, Song, Xie, Jun, Yan, Zhantao, Zhang, Xian, Zong, Yun, Han-Zhang, Han, Li, Qing, Li, Chong

Testu osoa Testu osoa Testu osoa

IBI362 (LY3305677), a weekly-dose GLP-1 and glucagon receptor dual agonist, in Chinese adults with overweight or obesity: A randomised, placebo-controlled, multiple ascending dose... nork Ji, Linong, Jiang, Hongwei, An, Pei, Deng, Huan, Liu, Meng, Li, Li, Feng, Liqi, Song, Baili, Han-Zhang, Han, Ma, Qingyang, Qian, Lei

Testu osoa Testu osoa Testu osoa

Comparison of genomic landscapes of large cell neuroendocrine carcinoma, small cell lung carcinoma, and large cell carcinoma nork Zhou, Zhen, Zhu, Lei, Niu, Xiaomin, Shen, Shengping, Zhao, Yi, Zhang, Jie, Ye, Junyi, Han‐Zhang, Han, Liu, Junjun, Liu, Chenglin, Lu, Shun

Testu osoa Testu osoa Testu osoa

Parallel serial assessment of somatic mutation and methylation profile from circulating tumor DNA predicts treatment response and impending disease progression in osimertinib-treat... nork Xia, Shu, Ye, Junyi, Chen, Yu, Lizaso, Analyn, Huang, Le, Shi, Lei, Su, Jing, Han-Zhang, Han, Chuai, Shannon, Li, Lingling, Chen, Yuan

Testu osoa Testu osoa Testu osoa

Distinctive genomic characteristics in POLE/POLD1-mutant cancers can potentially predict beneficial clinical outcomes in patients who receive immune checkpoint inhibitor nork He, Junjun, Ouyang, Wei, Zhao, Wugan, Shao, Lin, Li, Bing, Liu, Bihao, Wang, Dejuan, Han-Zhang, Han, Zhang, Zhou, Shao, Liang, Li, Wencai

Testu osoa Testu osoa Testu osoa

Efficacy of erlotinib as neoadjuvant regimen in EGFR-mutant locally advanced non-small cell lung cancer patients nork Xiong, Liwen, Lou, Yuqing, Bai, Hao, Li, Rong, Xia, Jinjing, Fang, Wentao, Zhang, Jie, Han-Zhang, Han, Lizaso, Analyn, Li, Bing, Gu, Aiqin, Han, Baohui

Testu osoa Testu osoa Testu osoa

Liquid biopsy in extranodal NK/T-cell lymphoma: a prospective analysis of cell-free DNA genotyping and monitoring nork Qi, Fei, Cao, Zheng, Chen, Bo, Chai, Yue, Lin, Jing, Ye, Junyi, Wei, Yuce, Liu, Hao, Han-Zhang, Han, Mao, Xinru, Feng, Xiaoli, Dong, Mei

Testu osoa Testu osoa Testu osoa

Mutational landscape and clonal diversity of pulmonary adenoid cystic carcinoma nork Li, Min, Zhao, Bing-Rong, Liu, Shi-Qing, An, Jian, Deng, Peng-Bo, Han-Zhang, Han, Ye, Jun-Yi, Mao, Xin-Ru, Chuai, Shao-Kun, Hu, Cheng-Ping

Testu osoa Testu osoa Testu osoa

Characterization of Frequently Mutated Cancer Genes and Tumor Mutation Burden in Chinese Breast Cancer nork Xiao, Weikai, Zhang, Guochun, Chen, Bo, Chen, Xiaoqing, Wen, Lingzhu, Lai, Jianguo, Li, Xuerui, Li, Min, Liu, Hao, Liu, Jing, Han-Zhang, Han, Lizaso, Analyn, Liao, Ning

Testu osoa Testu osoa Testu osoa

Mutational Landscape of PI3K-AKT-mTOR Pathway in Breast Cancer: Implications for Targeted Therapeutics nork Xiao, Weikai, Zhang, Guochun, Chen, Bo, Chen, Xiaoqing, Wen, Lingzhu, Lai, Jianguo, Li, Xuerui, Li, Min, Liu, Hao, Liu, Jing, Han-Zhang, Han, Lizaso, Analyn, Liao, Ning

Testu osoa Testu osoa Testu osoa

A phase 1b randomised controlled trial of a glucagon-like peptide-1 and glucagon receptor dual agonist IBI362 (LY3305677) in Chinese patients with type 2 diabetes nork Jiang, Hongwei, Pang, Shuguang, Zhang, Yawei, Yu, Ting, Liu, Meng, Deng, Huan, Li, Li, Feng, Liqi, Song, Baili, Han-Zhang, Han, Ma, Qingyang, Qian, Lei, Yang, Wenying

Testu osoa Testu osoa Testu osoa